Where can I learn more about this study? 
You can find more information about this study on the websites listed below. 
- www.clinicaltrials.gov Once you are on the website, type "NCT04564040" into the search box and click "Search" 
- www.AstraZenecaClinicalTrials.com Once you are on the website, type "D8223C00005" into the search box, and click "Find a Study". 

Full Study Title: A 2-Part, Phase I, Open-label, Single-dose, Sequential, Randomized, Crossover Study of Acalabrutinib Tablet Suspension Delivered via Nasogastric Tube in Healthy Subjects to Evaluate Relative Bioavailability and Proton-pump Inhibitor (Rabeprazole) Effect 

AstraZeneca AB Protocol Number: D8223C00005 
National Clinical Trials Number: NCT04564040 

AstraZeneca, AB sponsored this study and has its headquarters in Södertälje, Sweden. 

The phone number for the AstraZeneca Information Center is +1-877-240-9479. 

Thank you! 

Clinical study participants belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for patients. 

The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies. 
CISCRP | One Liberty Square, Suite 1100 \u2022 Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org 

Version 1.0 2021_08_12